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BERYLLIUM NITRATE SUPPORTS FIBROBLAST MIGRATION AS AN 
ESSENTIAL COMPONENT OF SKIN AND LIMB REGENERATION IN AXOLOTLS 
 
 
 Tissue regeneration in salamanders is a robust process that is not easily 
interrupted or altered.  Therefore, inhibiting regeneration provides a means to interrogate 
the underlying cellular and molecular mechanisms regulating this complex event.  Here 
we show that application of a relatively low concentration of beryllium nitrate solution 
(100mM) causes a delay in skin regeneration and severely alters normal limb 
regeneration.  We provide evidence showing a beryllium-induced reduction in dermal 
fibroblast migration in vivo and in vitro.  We link this phenomenon to delayed 
regeneration of the skin and abnormal blastema formation resulting in limb patterning 
defects during regeneration.  Though our results show a slight reduction in fibroblast 
proliferation during the early stages of limb regeneration, we attribute this to an overall 
reduction in fibroblast presence at the site of injury.  Keratinocytes appeared 
unresponsive to beryllium treatment with the rates of re-epithelialization and proliferation 
not significantly different between treatment and control groups.  Taken together, these 
data reinforce a necessary role for fibroblasts during tissue regeneration and show that 
beryllium nitrate inhibits normal fibroblast behavior.  
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CHAPTER 1 
INTRODUCTION 
 Salamanders and newts are unique among tetrapods for their almost limitless 
ability to regenerate complex tissues and organs, including an entire limb (Butler and 
Ward, 1967; Eguchi et al., 2011; Wallace, 1981). Amazingly, this ability is not restricted 
to a single regeneration event as repeated bouts of newt limb amputation continuously 
produce new limbs (Spallanzani, 1769).  This example underscores the robust nature of 
regeneration and hints at the importance of local cells to continually divide and supply 
the raw material to faithfully restore a functional limb.  Limb regeneration in salamanders 
and newts represents an example of epimorphic regeneration whereby cell proliferation 
precedes morphogenesis to restore the missing appendage.  As cells aggregate at the 
injury site they form a blastema, a transient mass of lineage restricted progenitor cells.  
Both blastema formation and blastemal cell proliferation are absolutely required for 
successful regeneration following limb amputation.   
Despite the robust nature of epimorphic regeneration, a few techniques can be 
employed to significantly alter and even completely inhibit regeneration of the limb.  
There are three classically defined ways to inhibit appendage regeneration: (1) severing 
the nerve supply, (2) disrupting positional information and (3) inhibiting cell 
proliferation.  Examples of nerve dependence can be seen in early regeneration studies on 
amphibians.  When nerves were severed prior to an amputation of the limb, a blastema 
failed to develop and regeneration would not occur until the nerve supply had been 
restored (Brockes, 1987; Schotté and Butler, 1941; Singer, 1951; Todd, 1823).  While 
effective, the effect of denervation is not permanent since neurons regrow into the limb 
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stump a short time after the procedure.  Re-amputation of a previously denervated limb 
will lead to normal regeneration (Salley and Tassava, 1981).   
Dermal fibroblasts play a fundamental role during blastema formation and contain 
essential patterning information required for limb regeneration (Bryant and Gardiner, 
1989; Bryant et al., 2002a; Bryant et al., 2002b; Gardiner et al., 1986; Lheureux, 1975b; 
Muneoka et al., 1986).  Following an injury and peak inflammatory response, fibroblasts 
migrate to the wound site, interact locally, and deposit extracellular matrix (ECM), which 
directs cellular proliferation and migration (Calve et al., 2010; Seifert et al., 2012).  The 
interaction of cells from different circumferential locations is absolutely required for 
proper blastema formation (Carlson, 1974; Lheureux, 1975a; Lheureux, 1975b). 
Disturbing this pattern by perturbing the normal dorsal-ventral, anterior-posterior, or 
proximal-distal axes can cause aberrations in regeneration ranging from supernumerary 
limbs to the complete inhibition of regeneration (Bryant, 1976; Slack, 1983).  
Proliferation, outgrowth, and differentiation of cells within the blastema formalize their 
positional identities, establishing the future pattern of the new limb.   
Various chemical and molecular inhibitors have been used to probe the 
mechanisms that contribute to regeneration in salamanders.  Examples include colchicine, 
LE135, Chloramphenicol, and Actinomycin D to name a few (Burnet and Liversage, 
1964; Carlson, 1967, 1969; Del Rincon and Scadding, 2002; Thornton, 1943).  Retinoic 
acid (RA) treatment can proximalize limb stump cells in salamanders and newts, 
inducing regeneration of a full limb (e.g., zeugopod, stylopod and autopod) from a distal 
plane of amputation (Maden et al., 1985).  The absence of RA during limb regeneration 
completely inhibits regeneration, as shown by the application of the retinoid antagonist 
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LE135 (Del Rincon and Scadding, 2002).  The mechanism for this phenomenon has been 
previously elucidated, with RA treatment upregulating the expression of homeobox gene 
Meis1, normally expressed proximally in the developed limb (Qin et al., 2002).  
Overexpression of Meis1 in distal cells results in proximalization of affected cells in the 
absence of RA (Mercader et al., 1999).  Exposing axolotl epidermis to Actinomycin D 
temporarily inhibits regeneration by delaying the formation of the apical ectodermic cap 
(Carlson, 1969).  Actinomycin D was later revealed to inhibit RNA transcription by 
binding to DNA and hindering RNA polymerase during elongation (Sobell, 1985).   
Chloramphenicol is a powerful antibiotic that has been used for over half a century.  It is 
also known for its potential adverse effects on the patient, most notably its damaging 
effect on mitochondria (Yunis, 1989).  In fact, treating Notopthalmus viridescens with 
chloramphenicol is sufficient to inhibit limb regeneration (Burnet and Liversage, 1964).  
Thornton (1943) demonstrated that Colchicine can inhibit limb regeneration in larval 
salamanders, and this was later shown to result from Colchicine-induced nerve damage 
and inhibited cellular proliferation (Singer et al., 1956).  In some cases, these compounds 
had toxic side effects on the entire organism, broadly inhibited cellular processes, or 
negatively impacted cell proliferation.  
In 1949, Charles S. Thornton demonstrated that briefly exposing newly amputated 
limbs to the alkaline earth metal beryllium, a compound not utilized by living organisms 
in basic cellular functions, completely inhibited limb regeneration in juvenile marbled 
salamanders (Ambystoma opacum).  Using contralateral limbs as control, the beryllium-
exposed limbs did not regenerate, whereas the contralateral limb regenerated normally.  
Beryllium was the only element of the alkali metal and alkaline earth metal groups shown 
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to inhibit regeneration, as Needham (1941) tested multiple elemental compounds of 
similar grouping on the periodic table and found that no other metal could inhibit 
regeneration at the same exposure time and concentration.  Even lithium, an element very 
similar to beryllium, had only a minor impact on regeneration and only at much higher 
concentrations and exposures.  One recent study in Xenopus suggested that beryllium acts 
as a potent mediator of inflammation to inhibit larval limb regeneration and another study 
suggested that beryllium inhibits cellular function by antagonizing the PIP3 inositol 
pathway (Mescher et al., 2013; Tsonis et al., 1991).  In light of these studies, and with the 
mechanism of beryllium inhibition of regeneration still a mystery, we asked whether 
beryllium nitrate might affect the immune response to injury, cell proliferation, death and 
migration.   
We used the axolotl (Ambystoma mexicanum) to explore the underlying basis of 
beryllium inhibition of regeneration. Using a full-thickness excisional skin wound model 
(Seifert et al., 2012) and classic limb amputations we show that beryllium exposure dose 
not increase immune cell infiltration or increase cell death.  Instead, using in vivo and in 
vitro techniques we show that beryllium inhibits axolotl fibroblast migration and that this 
affects extends to human fibroblasts as well without a concomitant increase in cell death.  
Surprisingly, we find that limb regeneration in the axolotl is not completely inhibited, and 
that beryllium exposure delays, rather than inhibits, skin regeneration. 
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METHODS 
Animals 
Ambystoma mexicanum (Mexican axolotl) were acquired from the Ambystoma 
Genetic Stock Center (AGSC, Lexington, KY) or from our laboratory colony.  Animals 
were housed individually in an aquatic flow-through system at 17-18˚C in modified 
Holtfreter’s Solution and maintained on California blackworms (Lumbriculus variegatus, 
J.F. Enterprises, Oakdale, CA).  All procedures were conducted in accordance with, and 
approved by, the University of Kentucky Institutional Animal Care and Use Committee 
(IACUC Protocol: 2013-1174). 
 
Full-thickness Excisional (FTE) Wounding and Limb Amputations  
Adult axolotls were anesthetized by full submersion in Benzocaine (Sigma-
Aldrich, St. Louis, MO) 0.01% (aqueous).  Sterile 4mm biopsy punches (Sklar 
Instruments, West Chester, PA) were used to create full thickness epithelium (FTE) 
wounds through the skin into the dorsal muscle.  Four wounds were created per animal on 
the dorsal surface posterior to the forelimbs and anterior to the hindlimbs.  In order to 
harvest wound tissue at specific time-points, animals were anesthetized as above and the 
entire wound was harvested by cutting around the wound with iridectomy scissors.  For 
limb amputations, each limb was amputated through the lower humerus of the forelimbs 
perpendicular to the limb with scissors.  The protruding bone was trimmed to the stump 
to aid wound closure and regeneration.  The regenerating limb was harvested by 
amputating just proximal to the original cut site.  The left limb and left FTE wound 
always served as the experimental group, while the right always served as the control.  
Skin wounds were harvested at particular time points post injury based on our previous 
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analysis of skin regeneration in axolotls (Seifert et al., 2012).  Limbs were harvested 
according to well-established morphological stages of regeneration (Wallace, 1981).   
 
Beryllium Nitrate (BeN) Treatment 
 A 100mM working stock of beryllium nitrate was prepared by diluting a stock 
solution (35% w/v) (Sigma-Aldrich) in distilled water.  Following a single limb 
amputation or FTE wound, animals were placed in 100mM BeN for 2 minutes, after 
which they were continually rinsed in running tap water for 10 minutes.  After rinsing in 
water, either the contralateral limb or a second wound corresponding to the mirror 
position across the dorsal midline was made and the injuries were allowed to regenerate.  
In this way, each animal served as its own control.  For in vitro experiments, three 
dilutions of BeN were prepared (1mM, 10mM and 100mM) and tested for cytotoxicity.  
Cytotoxicity and cell death was assessed using the vital dye Trypan Blue.  Based on these 
tests 10mM BeN was used in all subsequent cell culture experiments.  
 
Histology and Immunohistochemistry 
Harvested tissues were fixed in 10% neutral buffered formalin (NBF) (American 
Master Tech Scientific Inc., Lodi, CA) overnight (~16-24hr), washed in phosphate 
buffered saline (PBS) (MP Biomedicals LLC, Santa Ana, CA) 3 times, and dehydrated in 
70% EtOH.  Samples were stored in 70% EtOH at 4˚C until being processed for paraffin 
embedding.  Limb samples were decalcified in 10% EDTA (pH 7.4) for 3 days at room 
temperature with daily changes before processing.  All tissue processing was completed 
at the University of Kentucky using a rapid microwave histoprocessor (Milestone 
Medical Technologies, Kalamazoo, MI).  Tissue was embedded in paraffin (Leica 
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Biosystems, Buffalo Grove, IL) and 5 µm sections were placed onto Superfrost Plus 
slides (Fisher Scientific).  Tissue sections were processed for routine histology and 
stained with Masson’s trichrome (Richard-Allen Scientific, Kalamazoo, MI), Picrosirius 
Red (American Master Tech) or Alcian Blue (Sigma-Aldrich).  For frozen sections, 
samples were fixed for 1 hour in 10% NBF at 4˚C, washed in PBS, equilibrated in 30% 
sucrose and OCT freezing medium, and rapidly frozen on dry ice to be stored at -20ºC.  
Frozen sections where cut at 12µm.   
For general immunohistochemistry preparation, slides were deparaffinized, 
rehydrated and antigen retrieval was performed if necessary (see below for each 
antibody).  Sections were then washed in tris-buffered saline (TBS), blocked for biotin 
and streptavidin at 15 minute intervals each (Vector Labs Inc., Burlingame, CA), and 
incubated with 1˚ antibody (see below) overnight at 4˚C.  Isotyped IgGs matching the 
primary antibody were run as negative controls. The following day, slides were washed 
in TBS, incubated with biotinylated 2˚ antibody (Vector Labs) for 30 minutes and 
subsequently incubated with streptavidin conjugated horseradish peroxidase antibody 
(Vector Labs) for 30 minutes.  The antibodies were visualized using DAB (3,3-
diaminobenzidine) (Vector Labs) or incubated with a streptavidin conjugated Alexa-
Flour 594 (Invitrogen, Carlsbad, CA).  Nuclei were counterstained with either 10µg/ml 
Hoescht (Invitrogen) for fluorescence or Mayer’s hematoxylin for bright field 
visualization.  Coverslips were mounted using either ProLong Gold mounting medium 
(Invitrogen) for fluorescence or Cytoseal XYL (Thermo-Fisher) for bright field 
visualization. 
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For BrdU immunohistochemistry, a 3% hydrogen peroxide in methanol block was 
applied for 10 minutes prior to rehydration of the deparaffinized sections.  Slides were 
incubated in a 2M HCl solution at 37ºC for 15 minutes and rinsed 4 times in distilled 
water.  Reagents A (Avidin DH) and B (Biotinylated Horseradish Peroxidase H) from the 
Vectastain ABC kit (Vector Labs) were mixed in a 1:1 ratio of A:B at a concentration of 
20µL of each reagent per mL TBS after the application of the biotinylated 2º antibody.  
Each slide was treated with this mixture for 30 minutes.  After a TBS rinse, reagents from 
the DAB substrate kit (Vector Labs) were mixed according to the kit instructions (1 drop 
buffer solution, 2 drops DAB stock solution, 1 drop hydrogen peroxide solution, in 
2.5mL distilled water).  The mixture was applied to each slide individually, observed 
through a microscope, and timed for consistency among samples.  The reaction was 
immediately quenched in distilled water once time elapsed.  Slides were counterstained 
with Mayer’s hematoxylin for 10 seconds and rinsed in distilled water.  All slides were 
dehydrated to 100% EtOH, cleared in xylenes, and mounted using Cytoseal XYL.  
For EdU immunohistochemistry, sections were deparaffinized and rehydrated in 
TBS prior to treatment with EdU labeling reagents.  Each slide was incubated in the dark 
for 30 minutes with 220µL of an EdU-labeling master mix consisting of 11µL of 2M Tris 
at pH 8.5, 4.4µL of 50mM copper(II) sulfate, 0.44µL of Alexafluor azide (Invitrogen) at 
0.5mg/mL, 44µL of 0.5M ascorbic acid, and 160.6µL of ddH2O.  After a rinse with TBS, 
sections were exposed to 1µg/mL Hoescht for 5 mins in the dark, rinsed for 5 mins with 
ddH2O, and mounted with ProLong Gold. 
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Antibodies  
For paraffin sections; L-plastin (gift of P. Martin) 1:2000, Tenascin-c (Millipore, 
AB19013), anti-BrdU (Accurate Scientific) 1:500, and Collagen I (Rockland Inc., 
Limerick, PA) 1:500, Ambystoma fibronectin (gift of Thierry Darribere) 1:300.  Antigen 
retrievals used were; microwave and citrate buffer (pH. 6.0) (L-plastin, Tenascin-c, anti-
BrdU) for 20 minutes or proteinase K treatment (DAKO) for 2 minutes (collagen type I, 
fibronectin).  Negative controls were run using appropriate IgGs at the same 
concentration as the 1˚ antibody.  A GFP filter was used to detect autofluorescing 
erythrocytes. 
 
Analysis of Cell Death and Proliferation 
Cells undergoing apoptosis were detected using a TUNEL assay employing a 
GFP tag (Roche Life Sciences, Indianapolis, IN).  A cell death index was calculated for 
dermal cells expressing GFP divided by the total number of cells (stained with Hoescht) 
present in the same counting field.   
To detect cells that transitioned through S-phase, 100mg/kg BrdU was IP injected 
into axolotls and tissues were harvested after 24 hours.  Detection was carried out on 
formalin-fixed, paraffin embedded tissue sections.  After sectioning, sections were 
deparaffinized, blocked for endogenous peroxidase activity (see DAB 
immunohistochemistry above), rehydrated, antigen retrieved using pH 6.0 sodium citrate 
buffer in a rapid microwave histoprocessor (Micron Instruments, Inc. Carlsbad, CA) for 
20 minutes, rinsed thoroughly in water and placed in TBS.  The standard horseradish 
peroxidase visualization protocol was then followed (see DAB immunohistochemistry 
above).  Further detection of S-phase transition was conducted with 10µg/g EdU, which 
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was IP injected into axolotls as described above.  Samples were harvested after 24 hours, 
formalin fixed, paraffin embedded, and sectioned.  The fluorescent visualization protocol 
was then followed (see EdU immunohistochemistry above).   
 
GFP Tissue Transplantations 
 To track dermal fibroblasts in vivo, full-thickness skin comprising dermis and 
epidermis was extracted from the dorsal flank of axolotls constitutively expressing GFP 
(n=5 individuals per group) in all cell types (see Figure 6A).  Identical injuries were made 
on wild type (WT) individuals of approximate age and size.  Two wounds were made on 
WT animals at least 1cm apart, one for treatment with BeN and the other as a control.  A 
GFP tissue graft was placed into the open wound on WT animals and attached with 
Vetbond (3M, Saint Paul, MN).  Wounds were allowed to heal and integrate with host 
tissue for 2 weeks.  After 2 weeks, a second injury was made in the center of the 8mm 
GFP transplant using a 4mm biopsy punch.  The anterior-most transplant of each animal 
was injured first and treated with 100mM BeN for 2 minutes followed by a 10-minute 
rinse (see BeN treatment above).  A biopsy was taken from the remaining transplant and 
this wound served as the control.  Each transplant was harvested 14 days later using an 
8mm biopsy punch and preserved for cryosectioning.  Using this methodology, GFP+ 
cells in the wound bed were expected to represent fibroblasts because: (1) GFP epidermis 
in the original donor tissue was covered and replaced by host WT epidermis, (2) 
circulating host blood and immune cells were not GFP+, and (3) the majority of 
fibroblast cells are locally derived from a 200-500µm area immediately surrounding the 
injury (Mchedlishvili et al., 2007), which constitutively expressed GFP. 
 
   11 
Microscopy and Image Acquisition   
Bright-field images were taken on a BX53 light microscope (Olympus, Tokyo, 
Japan) using a DP80 CCD camera (Olympus).  Whole mount images were taken on an 
SZX10 light microscope (Olympus) using a DP73 CCD camera (Olympus).  All in vitro 
plate images were taken on an IX71 inverted microscope (Olympus) with a DP72 CCD 
camera (Olympus).  Tissue from a minimum of three individuals was used for 
quantitative data.   
 
Circular Scratch Assays 
Two cell types were analyzed in vitro: human adult dermal fibroblasts (hADF) 
(gift of Karen Escheveri, acquired from Lonza Group Ltd., Walkersville, MD) and 
axolotl fibroblasts (AL1) (gift of Stephanie Roy).  Both cell types were expanded in T-25 
and T-75 cell culture flasks (Greiner Bio-One, Monroe, NC).  AL1 cells were grown in a 
media containing 60% L-15 (Leibovitz) Medium without L-glutamine (Sigma-Aldrich), 
32% ddH2O, 5% fetal bovine serum (FBS) (GE Healthcare Bio-Sciences, Pittsburgh, 
PA), 1% insulin/selenium/transferrin (Life Technologies, Grand Island, NY), 1% 
penicillin/streptomycin/amphotericin-b (Sigma-Aldrich), and 1% L-glutamine (Life 
Technologies).  The hADF cells were grown in a media containing 88% Dulbecco’s 
Modified Eagle Medium/F-12 (DMEM) (Life Technologies) 10% FBS (GE Healthcare 
Bio-Sciences), 1% insulin/selenium/transferrin (Life Technologies), 1% 
penicillin/streptomycin/amphotericin-b (Sigma-Aldrich).  Cells were passaged at 70-80% 
confluency.  Cells were passaged by rinsing with Dulbecco’s PBS solution (DPBS) (Life 
Technologies), treating with 0.25% Trypsin-ETDA (Life Technologies) for 3-5 minutes, 
and centrifuging for 3 minutes at 3000rpm.  Each cell line was split 1:2 or 1:3 into new 
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flasks with fresh media until a large stock of cells was obtained.  Additional cells were 
slowly frozen in media with 10% DMSO at -80ºC and stored long-term in liquid nitrogen.  
Both cell types were grown in 12-well tissue culture treated plates and allowed to reach 
~80% confluency prior to any procedure.  Half of the wells were treated with 10mM 
beryllium nitrate and rinsed 3 times with DPBS. Cells were then scraped off with a cotton 
tip applicator in the very center of each well. Images were taken every 12 or 24 hours up 
to 96 hours (hADF cells) or 14 days (AL1 cells) following treatment.  
 
Statistics 
Basic statistical comparisons between control and experimental groups were 
conducted using JMP software (SAS, Cary, NC) to report standard deviation, standard 
error of the mean, and to conduct an independent t-test of unequal variance.  T-tests were 
used to measure differences in cell proliferation in the dermis and epidermis of FTE skin 
wounds, differences in fibroblast numbers in the regenerating dermis, and differences 
among the percent of AL1 and hADF cells in various stages of the cell cycle. 
A two-way ANOVA was used to determine if there were any significant 
differences in apoptosis among treated and untreated skin wounds depending on the day 
of regeneration, the experimental group, and the interaction between day and group.  
Alpha was set at 0.05. 
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RESULTS 
In order to investigate the effect of beryllium on regenerative ability, we first 
sought to replicate C. S. Thornton’s original experiments showing that a short beryllium 
exposure completely inhibited limb regeneration (see Methods) (Thornton, 1949, 1950, 
1951).  Replicating the originally published parameters and substituting juvenile axolotls 
(Ambystoma mexicanum) for Ambystoma opacum larvae, we found that limb regeneration 
was severely perturbed, but not completely inhibited, in response to beryllium nitrate 
(BeN) exposure (Figure 1).  Examining control limbs after amputation, we found that a 
blastema formed in all animals and progressed through the normal stages of limb 
regeneration, ultimately leading to complete regeneration of a normal stylopod, zeugopod 
and autopod (Figure 1A-C).  In contrast, BeN treated limbs formed a small edema at the 
amputation plane that persisted until control limbs had already formed digits (Figure 1D).  
Analyzing BeN treated limbs 98 days after injury (D98), we observed very small, 
mispatterned limbs that were well-vascularized (Figure 1E).  By D200, some 
melanocytes had migrated distally, but limbs remained heteromorphic (Figure 1F). While 
the presence of digits and the number was variable across all BeN treated animals, 
melanocyte migration was always disrupted (Figure 1E-F).  Similar to previous studies, 
we found that the degree to which limb regeneration was inhibited was dependent on the 
size of the animal and the concentration of beryllium; larger animals required a higher 
molar concentration to inhibit limb regeneration (data not shown).  We followed some 
animals for up to two years after BeN exposure and observed no adverse health affects.  
Animals continued to grow and reproduce, which supported previous assertions that 
beryllium inhibited regeneration locally, rather than altering whole organism physiology 
(Thornton, 1949).   
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Seeking to remove the complexity of limb patterning in order to investigate how 
beryllium might inhibit regeneration, we turned to a full-thickness skin defect.  Our 
previous work showed that adult paedomorphic axolotls could completely regenerate a 4 
mm full-thickness excisional skin wound in 80 days (Seifert et al., 2012) and we 
observed a similar time course during our experiments (Figure 2A, C, E, G).  We 
compared BeN treated skin wounds to control wounds and noted several important 
effects (Figure 2B, D, F, H).  D14 BeN treated wounds showed a similar response to BeN 
treated limbs and were notable for a lack of pigment cells migrating into the wound, 
persistent presence of edema in the wound bed and increased wound area compared to 
controls (Figure 2B).  Tracking wounds over time we noted a difference in wound area 
between treatment and control groups beginning at D14 (Figure 2A, B).  By D21, control 
wounds were significantly smaller than BeN treated wounds (9.93 ± 0.91mm2 and 28.77 
± 2.82mm2 respectively, t = 6.20, p < 0.002; n=5 per group).  In fact, wound area in BeN 
treated wounds had more than doubled compared to the original wound area (original 
wound = 12.57 mm2 vs. D21 BeN wound area = 28.77 ± 2.82mm2).  Whereas the original 
wound was difficult to visualize at D64 in control samples, treatment wounds were still 
visible at this time point, but became harder to detect by D80 (Figure 2E-H).  These 
results suggested that BeN exposure inhibited wound contraction following injury.  
We next examined the cellular structure of healing wounds and found that 
keratinocytes re-epithelialized treatment and control wounds in 24 hours (data not 
shown).  A thin layer of keratinocytes and Leydig cells covered all wounds within 24 
hours of injury and wounding elicited a typical hemostatic response (Figure S1).  While 
blood cells were present in treatment and control wounds, a large number of erythrocytes 
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and plasma persisted in BeN treated wounds until D21 (Figure 2B, D and Figure 3).  In 
parallel with greater numbers of erythrocytes, ECM deposition was strongly inhibited by 
BeN treatment.  While we detected collagen in control wounds beginning at D14, 
collagen deposition was not detected in treatment wounds until after D21 (Figure 3).  In 
D42 control wounds, the regenerating dermis began stratifying into an upper stratum 
spongiosum and lower stratum compactum, and new glands were evident regenerating 
from the epidermis (Figure 3).  By D80, skin in control wounds had completely 
regenerated and resembled unwounded skin (Figure 3).  In contrast, D42 BeN treated 
wounds developed a dense dermal ECM layer associated with the basement membrane 
and no regenerating glands were present (Figure 3).  Surprisingly, D80 wounds in BeN 
treated skin resembled D42 control wounds, whereby the collagen-rich dermal layer 
began subdividing and new glands were evident descending from the epidermis (Figure 
3).  At D139, there was little noticeable difference between treatment and control 
wounds.  Together, these data demonstrated that BeN exposure delayed, but did not 
inhibit skin regeneration.  
Our observation of reduced collagen deposition following BeN treatment led us to 
ask whether other components of the extracellular matrix normally deposited during skin 
regeneration were similarly affected (Seifert et al., 2012).  Analyzing wound bed tissue at 
D14, we found that fibronectin-1 (FN1) and tenascin-C (TNC) were deposited throughout 
the regenerating dermis (Figure 4).  We also used Alcian blue to detect 
glycosaminoglycan (GAG) production and found it present throughout the wound bed in 
control skin (Figure 4).  In contrast to control treated wounds, FN1 and TNC were barely 
detectable in BeN treated wounds (Figure 4).  Similarly, GAGs were not present in the 
   16 
wound bed of the treatment group (Figure 4) at D14.  Together with our histological 
observations, these results indicated that BeN inhibits ECM deposition (directly or 
indirectly) and this is associated with a delay in the normal time course of skin 
regeneration.   
A lack of ECM production in BeN treated wounds suggested three hypotheses: 
(H1) a persistent inflammatory response prevented progression to a regenerative response 
or (H2) fibroblasts were not present and persistent in the wound or (H3) fibroblasts were 
not migrating into the wound bed.  We first sought to test whether BeN treatment 
increased cellular inflammation in the wound bed.  We assessed leukocyte numbers using 
an antibody to L-plastin, a pan-leukocytic marker (Jones et al., 1998; Seifert et al., 2012).  
Calculating percent L-plastin+ cells in the wound bed at D7, we found significantly fewer 
cells in BeN treated versus control wounds (0.20 ± 0.17% and 3.09 ± 0.49% respectively, 
t = -6.10, p < 0.003) (Figure 5).  This data showed that BeN did not stimulate increased 
inflammatory cell influx into dorsal skin wounds, although erythrocytes and plasma were 
found to persist longer in the wound bed in BeN treated wounds.   
 Dermal fibroblasts are the primary cell type involved in blastema formation 
(Gardiner et al., 1986, Muneoka et al., 1986) and are responsible for producing ECM 
during regeneration (Asahina et al., 1999; Calve et al., 2010; Gulati et al., 1983; Onda et 
al., 1990; Seifert et al., 2012).  The relative absence of ECM proteins in the wound bed of 
BeN treated wounds suggested fibroblasts might be absent from the wound bed, either 
because they failed to migrate into the wounds or because they failed to survive due to 
BeN exposure.  We tested multiple commercially available antibodies that label 
mammalian fibroblasts (PDGFR-alpha (R+D Systems), vimentin (Sigma-Aldrich), 40E-C 
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(Developmental Studies Hybridoma Bank) for their reactivity to axolotl dermal 
fibroblasts.  Although we used our robust immunohistochemical protocol and tested a 
number of variables, including paraffin sections (with various antigen retrievals) and 
frozen tissue sections, we were unable to reliably label axolotl fibroblasts (data not 
shown).  To circumvent this technical limitation, we took advantage of a transgenic 
axolotl line in which all cells constitutively express GFP (Sobkow et al., 2006).  We 
transplanted skin (epidermis and dermis) from axolotls that constitutively express GFP in 
all cells into WT hosts (whose cells do not express GFP) in order to track fibroblast 
presence and migration into injured tissue (Figure 6A).  We counted GFP+ cells at D14 
when fibroblasts are normally observed in the wound bed and ECM molecules are readily 
detectable (Figure 3 and 4).  We found 5.66 ± 1.9% and 0.33 ± 0.11% GFP+ cells in 
control and BeN treated wounds respectively (t = -6.44, p < 0.0001, 2-tailed t-test) 
(Figure 6B-D).  This confirmed that few fibroblasts were present in BeN treated wounds 
and suggested that BeN might induce cell death or restrict, either directly or indirectly, 
the migratory ability of fibroblasts into the wound. We performed a TUNEL assay on 
tissue harvested from control and BeN treated wounds at D1, D3, and D7 to test whether 
BeN treatment induced cell death in local fibroblasts and found no significant difference 
between groups at any time point (F = 0.2018, p = 0.9583, two-way ANOVA) (Figure 
7A-C).  Thus, our data showed that BeN treatment primarily affected fibroblast migration 
and does not induce cell death in local fibroblasts or in other wound bed cells.  
While our transplant experiment demonstrated that fibroblasts failed to move into 
the wound bed, we could not rule out that beryllium exposure might affect production of 
a chemotactic factor either from the epidermis or other cells within the wound bed.  To 
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directly test the affect of BeN on cell migration, we cultured axolotl AL1 cells (an 
immortalized dermal fibroblast line) and exposed them to BeN.  First we tested the 
cytotoxicity of three concentrations of BeN based on our 100mM in vivo treatment (i.e., 
1mM, 10mM and 100mM).  Using Trypan Blue to detect dead cells, we determined 
10mM BeN to be an optimal treatment concentration where minimal cell death occurred 
in response to treatment.  To assess migratory ability in vitro we created an artificial 
wound using a round sterile applicator in the center of each well of a 12-well plate 
(Figure 8).  Following cells every 24 hours we noted that control (untreated) cells began 
migrating into the in vitro wound on D2.  By D14 large numbers of untreated cells had 
migrated into the wound center (Figure 8).  In stark contrast, by D14 we found that few 
fibroblasts had migrated into the circular wound (Figure 8).  Because we conducted the 
assay at ~70-80% confluency, we assessed confluency outside the scratch at D14 and 
found that cells were confluent in control and treatment groups (Figure 8).  Together, 
these data show that axolotl fibroblasts treated with BeN exhibit greatly reduced 
migratory behavior compared to control cells without inhibiting cell division.  
We next asked if our findings could be expanded to mammalian cells and asked if 
BeN treatment reduced the migratory ability of human dermal fibroblasts (hADF cells) 
(Figure 9).  We performed the same in vitro assay as above and followed hADF cells 
every 12 hours (Figure 9).  Similar to axolotl AL1 cells, we found that a 10mM treatment 
with BeN reduced the migration of cells into scratch wounds.  Untreated hADF cells 
successfully migrated and completely filled an in vitro wound by 96 hours (Figure 9).  
Few BeN treated cells migrated into the scratched area by 96 hours and the area remained 
largely uninhabited by cells even 15 days after treatment (Figure 9 and data not shown).  
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We also noted a tendency of BeN treated cells to detach from the plastic and remain alive 
(Figure 9).  Examining cells outside of the scratched areas, we noted that while control 
wells reached 100% confluency, cells in treated wells remained at approximately 70% 
confluency suggesting limited cell growth (Figure 9).  
Although it appeared that axolotl fibroblasts continued growing after BeN 
treatment, the failure to reach confluency in hADF cells suggested BeN might affect cell 
cycle progression differently in various cell types.  Thus, we used flow cytometry to 
calculate the relative fraction of cells present in each phase of the cell cycle in order to 
gain insight into how BeN might affect cell cycle progression.  We first examined AL1 
cells.  Following control or BeN treatment, we allowed AL1 cells to continue cycling for 
48 hours (equal to at least one complete cell cycle) (Maden, 1978; Wallace and Maden, 
1976), labeled cells with propidium iodide, and then sorted cells based on their DNA 
content (Table 1).  Our analysis indicated that BeN treatment led to a small, but 
significant increase in the percentage of cells in S-phase and G2/M-phase (Table 1).  The 
percentage of cells in G0/G1, however, was not different between treatment and control.  
We next analyzed the effect of BeN treatment on proliferation of the regenerating limb in 
vivo with EdU during early blastema, mid blastema, and palette stages (Figure S2).  We 
found a reduction in the proliferative index of the BeN treated group during the blastema 
stages (early blastema: control = 20.03 ± 2.59%, treatment = 5.74 ± 1.37%, t = -4.89, p < 
0.001; mid blastema: control = 24.49 ± 0.75%, treatment = 14.71 ± 2.86%, t = -3.26, p < 
0.01), but a recovery of proliferation at a later stage (palette: control = 24.58 ± 3.29%, 
treatment = 26.40 ± 3.63%, t = 0.37, p = 0.71), suggesting either BeN was only 
temporarily affecting fibroblast proliferation, or the lack of fibroblasts during the early 
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stages of limb regeneration was skewing proliferation counts.  Interestingly, when we 
analyzed keratinocyte proliferation, we found no difference in the percent of BrdU+ cells 
comparing BeN treated epidermis and control epidermis at either 7 days after amputation 
(control = 10.56 ± 3.46%, treatment = 7.91 ± 1.77%, t = -0.78, p = 0.447) or 14 days 
following amputation (control = 18.15 ± 2.22%, treatment = 24.63 ± 2.29%, t = 2.06, p = 
0.048) (Figure S3).  Analyzing hADF cells in vitro, we found that BeN had a different 
effect on the mammalian cell cycle (Table 1).  In contrast to AL1 cells, we found a 
significant decrease in the percentage of cells in S-phase and G2/M, whereas the 
percentage of cells in G0/G1 increased by 20% (Table 1).  Together, this data suggests 
that BeN effects cell cycle progression differently in axolotl versus human cells.   
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DISCUSSION 
 Salamanders are known to regenerate their skin and limbs following injury.  
Many of the molecular mechanisms that define these processes remain to be discovered.  
In this study, we confirmed that beryllium nitrate (BeN) grossly altered regenerating 
Ambystoma mexicanum (axolotl) limbs.  Furthermore, we demonstrated that a similar 
application of BeN to full thickness skin injuries delayed, but did not inhibit skin 
regeneration and that BeN affected the ability of fibroblasts to migrate sufficiently into 
the wound bed.  This in turn resulted in little to no extracellular matrix deposition at the 
injury sites.  These results support the idea that fibroblasts must migrate into the injury 
site and that their presence is necessary for epimorphic regeneration. This is born out of 
observations that fibroblasts are necessary to establish a blastema, in the case of limb 
regeneration, or deposit and remodel the wound bed ECM in the case of skin 
regeneration.  Thus, our study provides a cellular mechanism underlying beryllium’s 
inhibitory effect on regeneration in salamanders.  Interestingly, our results also show that 
despite inhibiting local fibroblasts from migrating into skin injuries, additional fibroblasts 
from the periphery eventually arrive in the wound bed to regenerate the dermis.  
 Charles Thornton (1949, 1950, 1951) showed that limb regeneration of 
Ambystoma opacum larvae could be completely inhibited with the application of BeN to 
a limb stump without any adverse short-term effects to the rest of the organism.  Our 
experiments treating axolotl larvae with BeN produced stunted, heteromorphic limbs with 
few pigment cells and missing digits.  There are several explanations for our finding that 
limb regeneration was not completely inhibited.  First, complete versus partial inhibition 
could be attributed to species differences as the original studies used Ambystoma opacum 
larvae, although this is unlikely in our opinion given that beryllium inhibits regeneration 
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in other Ambystoma species, newts and Xenopus larvae (Mescher et al., 2013; Scheuing 
and Singer, 1957; Thornton, 1949, 1950, 1951; Tsonis et al., 1991).  Second, the effect of 
BeN as a regeneration inhibitor was reported to be size dependent (for a given 
concentration), with reduced effects observed on larger organisms (Thornton, 1949).  The 
axolotl larvae used in the present experiments were larger (7-9 cm) than the A. opacum in 
Thornton’s experiments (3-4 cm and 6-7 cm) and thus it is likely that a similar 
concentration of BeN (N/7) was insufficient to achieve complete inhibition.  It is also 
possible that beryllium may affect larval limbs more completely.   
Although previous studies showed that beryllium could completely inhibit limb 
regeneration in larval salamanders (Needham, 1941; Scheuing and Singer, 1957; 
Thornton, 1949; Tsonis et al., 1991), only one study has proposed a possible molecular 
mechanism which involves phosphatidylinositol phosphate (PIP) metabolism (Tsonis et 
al., 1991).  Inositol 1,4,5-trisphosphate (IP3) production was shown to rapidly increase 
following limb amputation and then rapidly decrease within 5 minutes (Tsonis et al., 
1991).  BeSO4 exposure caused a 22% decrease in PIP metabolism 30 seconds after 
amputation, although BeSO4 exposure at later time points had no affect on PIP 
metabolism.  While this study suggested that BeSO4 exposure inhibits regeneration by 
producing an inhibitory effect on cell proliferation because IP3 production has been 
linked to cell cycle activation and proliferation (Berridge, 1987), the authors provided no 
data on cell proliferation.  Scheuing and Singer’s work (1957) using newts also seems to 
provide an alternative to the proposed PIP mechanism whereby fully formed blastemas 
were directly infused with similar concentrations of BeN and regeneration was inhibited.  
Because the treatment occurred many days after injury when IP3 levels are low, it seems 
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unlikely that beryllium exerts its inhibitory effect through PIP metabolism.  However, it 
is possible that beryllium has multiple effects on regeneration, both immediately after 
amputation (PIP-IP3 metabolism) and at a later time (BeN infusion of blastemas).  We 
did find a small decrease in the proliferative index of cells beneath the epidermis at later 
time points, although we found no effect on keratinocytes.  Given our findings linking 
BeN exposure to a migration defect, it is likely that the decrease in cell proliferation is a 
consequence of few cells migrating into the wound bed.  Interestingly, evidence exists 
linking PIP metabolism to cell migration in vitro (Oppelt et al., 2012).  Further studies are 
required to determine if PIP metabolism is linked to reduced cell migration in salamander 
cells.   
Beryllium has been explored extensively in the context of chronic berylliosis 
disease whereby inhalation of beryllium dust causes an acute chronic inflammation of the 
lungs (Newman, 2007).  In mammals, this occurs via an acute immune response where 
beryllium is identified by the major histocompatibility complex and antigen-presenting 
cells that themselves stimulate the proliferation and accumulation of CD4+ helper T cells, 
forming granulomatous tissue in the bronchoalveolar lavage of the lungs (Saltini et al., 
1989).   Extended beryllium exposure to the skin also leads to an accumulation of CD4+ 
cells at the point of contact (Fontenot et al., 2002; Saltini et al., 1989).  Thus, depending 
on varying levels of susceptibility, the adaptive immune response in mammals is 
responsible for the symptoms associated with chronic berylliosis disease.  Interestingly, 
while much of the T-cell receptor complex has remained conserved between amphibians 
and mammals (Fellah et al., 1993), functional differences have occurred, specifically in 
the V-beta region of the T-cell receptor (Fellah et al., 1994).  Generally, the immune 
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response of ectothermic organisms is mild relative to the exacting response of the 
mammalian immune system and lacks the organization or memory provided by B-
lymphocytes, which are absent in axolotls (Hsu, 1998).  A recent study treated larval 
Xenopus laevis with a beryllium solution and showed that beryllium increased the 
inflammatory response and this attenuated regenerative ability (Mescher et al., 2013).  In 
contrast, our results in salamanders exposing limb amputations and skin wounds to BeN 
suggested that a sensitized immune system is not present following BeN exposure and 
did not account for the lapse in regeneration.  While we observed an edema composed of 
plasma and erythrocytes consistent with a prolonged hemostatic response, few 
inflammatory leukocytes were present at the treatment site.  Admittedly, no reagents exist 
to detect T-cells in salamanders so we could not assay for increased infiltration of these 
cells, and more importantly, T-cell polarization.  The depletion macrophages have been 
shown in axolotls to inhibit limb regeneration (Godwin et al., 2013).  While we cannot 
rule out the effect of macrophage reduction on regeneration, we infer that the effect of 
this deficit is playing a minor role when viewed in the context of our results and the role 
of fibroblasts in regeneration.  Taken together, the data suggests that beryllium can act as 
an immunostimulatory agent in frogs and mammals, but that immune stimulation does 
not underlie the inhibitory effect of beryllium on regeneration in salamanders.   
The dermal cell population has been reported to play a large role in limb 
regeneration by contributing up to 78% of the cells to the blastema (Muneoka et al., 
1986).  We showed that BeN reduces the ability for fibroblasts to migrate in vivo and in 
vitro.  Despite poor fibroblast migration during the early stages of regeneration in 
response to BeN, some fibroblasts eventually migrated into the injured areas.  As a result, 
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we observed a delay in skin regeneration, rather than an inhibition.  Where these 
additional cells come from is a mystery, although it is possible that there is a fluid 
exchange of fibroblasts within the dermis and that given enough time, unaffected 
fibroblasts eventually infiltrate the wound site in high enough numbers to produce new 
ECM and regenerate the dermis.  In the context of limb regeneration, the appearance of a 
few digits and carpals suggests that either a very small blastema formed or that a small 
accumulation of cells differentiated into the most distal structures. It remains unclear 
whether beryllium permanently affects the fibroblasts or if the effect eventually subsides, 
however, it is clear that the effect is sufficient to significantly alter limb regeneration and 
delay both skin and limb regeneration. 
 One of the major concern of exposing tissue or cells to a highly reactive element 
such as beryllium is the risk of toxicity to basic cellular processes (e.g., DNA synthesis, 
cell proliferation, cell death, transcription, etc.).  We addressed these concerns by 
quantifying DNA synthesis and by fluorescently labeling dying cells.  Beryllium toxicity 
has been cited as a caspase-dependent apoptotic pathway (Pulido and Parrish, 2003).  We 
were able to assess apoptosis through TUNEL labeling and found that BeN exposure did 
not increase the number of apoptotic cells in vivo.  Some studies suggest that beryllium 
has an antagonistic effect on cellular proliferation (Skilleter et al., 1983; Witschi, 1968).  
We did observe a small and transient reduction in cell proliferation in wound fibroblasts 
and mesenchymal cells beneath the epidermis, however fewer fibroblast cells were 
present following treatment.  Since we calculated the proliferative index based on cell 
density this finding suggests that the observed reduction of proliferation was caused by a 
shift in the ratio of fibroblasts to transient, non-proliferative erythrocytes and leukocytes.  
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Beryllium affects cell cycle progression, however the magnitude of its effect in vivo was 
likely overestimated.  Interestingly, proliferation of the epidermis was unaffected by BeN 
treatment which implies a targeted, cell-specific interaction rather than a ubiquitous 
cytotoxic response.  Our in vitro cell cycle analysis showed a small but significant 
increase in the number of cells in S-phase and a decrease in the number of cells in G2/M-
phase following BeN treatment which suggests a defect at the S/G2 checkpoint.  When 
we consider our in vivo and in vitro data together it appears as if BeN exposure also 
affects cell cycle progression, although as a secondary effect to cell migration since many 
cells present at the injury site are proliferating.  
We also conducted a cell cycle analysis on an hADF cell line and found that our 
results closely mirror those found for rat liver cells exposed to beryllium (Skilleter et al., 
1983).  We saw a significantly higher percentage of cells in G1-phase, and a significantly 
lower percentage of cells in S-phase and G2/M-phase.  Thus, in mammalian cells, 
beryllium exposure results in a more acute, disruptive response to cell cycling compared 
to axolotl cells in combination with its effect on fibroblast migration. 
 Thus, our study shows that beryllium appears to affect endogenous tissue 
regeneration in two distinct ways: first, through a disruption of cell migration and second, 
through a small, transient interruption of cell cycle progression.  It remains unclear if 
BeN operates as a mechanical impairment of the cell’s motility systems (extension and 
reduction of cytoskeleton or integrin binding) or a sensory impairment of surface 
receptors and cell signaling machinery. Our experiments have brought to light an 
interesting phenomenon with potential real-world applications in the ongoing effort to 
improve clinical efforts to antagonize scarring.  Scar formation in mammals results from 
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the production of excessive, densely packed collagen fibers following injury or in 
response to fibrotic disease.  Because BeN exposure appears to limit fibroblast migration 
in a cell-type specific manner, an indirect outcome is a reduction in fibrosis.  While this 
result reduced regenerative ability in a salamander, the in vivo effect in a mammalian 
injury may result in decreased scar formation.  Future studies could be conducted to 
demonstrate the efficacy of low-dose BeN application to mammalian skin injuries, 
particularly those prone to high levels of scarring such as frostbite or burn.  However, 
given the propensity of beryllium to elicit T-cell polarization, the immunostimulatory 
effects of beryllium may overwhelm any potential benefits as an anti-fibrotic. In this 
respect, beryllium appears to offer a unique tool to tease apart the intricacies of vertebrate 
regeneration and scarring. 
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TABLES 
 
Table 1.  Flow cytometric analysis of the cell cycle revealed that beryllium nitrate 
treatment produced an increased percentage of cells in S-phase and G2/M had an 
effect on the S/G2 transition in AL1 cells and on the G1/S phase transition in hADF 
cells. 
AL1 Cell Cycle Analysis 
Cell 
Population 
(n=3) 
Control 
(avg %) 
Control 
SEM (%) 
BeN Treated 
10mM (avg %) 
Treatment 
SEM (%) 
t-test 
(p) 
G0/G1 44.78 0.91 45.95 0.37 0.2977 
S 34.31 0.56 39.16 0.64 0.0047 
G2/M 20.91 0.36 14.89 0.31 <0.001 
hADF Cell Cycle Analysis 
Cell 
Population 
(n=4) 
Control 
(avg %) 
Control 
SEM (%) 
BeN Treated 
10mM (avg %) 
Treatment 
CV  (%) 
t-test 
(p) 
G0/G1 52.78 0.37 72.42 0.62 <0.001 
S 6.19 0.21 2.69 1.35 0.042 
G2/M 41.67 0.45 24.89 1.62 <0.001 
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FIGURES 
 
 
Figure 1.  BeN treatment delays blastema formation and alters patterning during 
axolotl limb regeneration.  Amputated limbs treated with BeN were imaged during 
regeneration alongside contralateral controls at D24 (A, D), D98 (B, E), and D200 (C, F) 
following injury.  (A) D24, control limbs showed normal differentiation of the digits, 
while BeN treated limbs showed edema (arrows) with no gross signs of blastema 
formation (D).  (B) Untreated limbs had completely regenerated by 98 days.  (E) D98 
BeN treated limbs exhibited a delay in regeneration and patterning defects. Moreover, 
few melanocytes had migrated into the regenerate (arrows).  Compared to control limbs 
at D200 (C), BeN treated limbs showed permanent malformations including atypical digit 
formation and reduced melanocyte numbers (F).  Scale bar = 1mm. 
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Figure 2.  Beryllium nitrate inhibits wound contraction and delays pigment cell 
migration.  (A-H) Comparison of full thickness excisional wound healing in control and 
BeN treated skin wounds in axolotls.  Wounds were followed for 80 days. (A, C) Control 
wounds contracted during first 21 days.  (B, D) BeN treated wounds expanded from 
initial biopsy area and retained large numbers of blood cells through D21.  The average 
area of treated wounds at D21 was 3x larger than control.  (E-F) Pigment cell 
(iridophore) migration was reduced in treated wounds.  (G-H) D80 control wounds were 
indistinguishable from the surrounding unwounded tissue, while treated wounds 
maintained a clearly defined wound edge with dermal tissue and muscle still visible 
through the epidermis.  Scale = 1mm. 
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Figure 3.  Beryllium nitrate exposure delays skin regeneration.  Masson’s trichrome 
stained sections comparing control and BeN treated full thickness excisional wounds in 
axolotls.  Control wounds showed ECM deposition at D14.  BeN treated wounds showed 
delayed ECM deposition until D42.  ECM deposited at D42 was tightly bundled and 
localized near the basal lamina.  Gland regeneration was apparent in control wounds at 
D42 and appeared at D80 in treated wounds.  Full thickness skin (dermis and epidermis) 
in control wounds had completely regenerated by D80 and resembled unwounded tissue.  
Skin regeneration was delayed in treated wounds, with dermis and epidermis mostly 
regenerated by D139.  Images represent center of the wound bed.  Blue = collagen, red = 
muscle, purple = cytosol, black = nucleus.  Scale = 100µm. 
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Figure 4.  BeN inhibits early deposition of extracellular matrix (ECM) proteins in 
D14 axolotl skin wounds.  Panels represent cross sections of full thickness skin showing 
epidermis (E), dermis (D) and muscle (M) in control and BeN treated wounds. 
Fibronectin-1, Tenascin-C and glycosaminoglycans (GAGs) are visible in the wound bed 
of controls, but are absent from BeN treated wounds. GAG presence was visualized with 
Alcian blue.  Scale = 50µm (Fibronectin), 100µm (Tenascin-C and GAG). 
 
 
 
 
Figure 5.  BeN treatment reduces leukocyte infiltration into skin wounds.  Axolotl 
skin sounds were harvested at D7, and leukocytes were detected with the pan-leukocytic 
marker L-plastin.  Control wounds contained significantly more L-plastin positive cells 
compared to BeN treated wounds (t = -6.10, p < 0.003).  Red arrows indicate L-plastin 
positive cells in control wounds.  Yellow cells are autofluorescing blood cells captured 
with the combination of a GFP and RFP filter. 
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Figure 6.  BeN reduces fibroblast migration into axolotl skin wounds.  (A) Schematic 
depicts experimental paradigm for tracking GFP-labeled fibroblasts.  8mm skin biopsies 
containing epidermis and dermis were harvested from the dorsal flank of ubiquitously 
GFP-expressing axolotls (n=5) and transplanted to 8mm wound beds created on WT 
animals.  Skin transplants were allowed to heal for 14 days after which a 4mm full 
thickness wound was made in the center of the transplant.  BeN treatment occurred 
immediately following injury (see Methods).  (B-D) Wound bed tissue was harvested at 
D14.  (B) Control wounds had significantly more GFP+ cells compared to BeN treated 
wounds.  (C-D) Red arrows indicate GFP+ cells.  Few GFP+ cells were detected in BeN 
treated wounds.  Erythrocytes that were auto-fluorescent at both red and green 
wavelengths and were not counted as GFP+.  Scale = 50µm. 
 
 
 
 
Figure 7.  BeN treatment does not affect cell death in vivo.  TUNEL assay was used to 
detect dying cells in axolotl wound bed tissue.  (A-C)  Percent dying cells were not 
different comparing control and BeN treated skin wounds across all time points examined 
(two-way ANOVA, F = 0.2018, p = 0.9583). Red arrows indicate TUNEL positive cells.  
Yellow cells are auto-fluorescent in both red and green wavelengths and thus were not 
counted as GFP+.  Scale = 50µm. 
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Figure 8.  Beryllium nitrate reduces migratory capabilities of axolotl AL1 fibroblast 
cells in vitro.  (A) Migration of AL1 fibroblasts across the inside edge (dotted line) of a 
circular scratch was tracked over the course of 10 days (red dots).  The shaded box 
indicates an area >90% filled with cells.  (B) BeN treatment inhibited migration of AL1 
cells and reduced total migration distance.  Dotted circle represents the original scratch 
area where untreated cells successfully migrated towards the center.  Cell density was 
~70-80% at treatment and cells in treated and control wells achieved confluency by D14 
(red boxed areas).  Red arrows indicate detached cells that were present in both treatment 
and control groups and did not stain with Trypan Blue (data not shown). 
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Figure 9.  Beryllium nitrate reduces human dermal fibroblast migration in vitro.  
(A) Migration of human dermal fibroblast (hADF) across the inside edge (dotted line) of 
a circular scratch was tracked over 48 hours.  Few cells treated with BeN migrated into 
the in vitro wound whereas control cells completely filled the wound after 96 hours (B).  
BeN treatment reduced cell confluence of hADF cells outside of the immediate scratch 
area (red box).  Red arrows show examples of cells in the treatment that have detached 
from the surface and did not stain with Trypan Blue (data not shown). 
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APPENDICES 
 
 
Figure S1.  Epidermis migration and wound closure is unaffected by BeN treatment.  
Axolotl dorsal flank wounds treated with 100mM BeN were sectioned and stained with 
Masson trichrome.  Epidermis covered the entire wound surface in both treatment and 
control after 24 hours.  BeN treated wounds appeared to have portions of the epidermis in 
which densely packed erythrocytes interrupted the contiguous layer of Leydig cells. 
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Figure S2.  Percent EdU+ cells at early blastema, mid blastema, and palette stages of 
limb regeneration following treatment with BeN.  Axolotl dorsal flank were wounds 
treated with 143mM beryllium nitrate, sectioned, and labeled with EdU.  Two random 
fields of view were imaged and quantified.  The treated limb bud had significantly fewer 
proliferating cells than the control in the early blastema (control = 20.03 ± 2.59%, 
treatment = 5.74 ± 1.37%, t = -4.89, p < 0.001) and the mid blastema (control = 
24.49±0.75%, treatment = 14.71 ± 2.86%, t = -3.26, p < 0.01).  The proliferative index 
was unchanged in the palette stage (control = 24.58 ± 3.29%, treatment = 26.40 ± 3.63%, 
t = 0.37, p = 0.71). 
 
 
 
 
Figure S3.  Proliferation of Leydig cells and keratinocytes of the epidermis was 
unaffected by BeN.  (B, C) Proliferating cells, indicated by yellow arrows, had 
incorporated BrdU and were counted against the total epidermal cell population.  (A) 
Proliferative indices were unaffected by the application of beryllium nitrate at both D7 
(control = 10.56 ± 3.46%, treatment = 7.91 ± 1.77%, t = -0.78, p = 0.447) and D14 
(control = 18.15 ± 2.22%, treatment = 24.63 ± 2.29%, t = 2.06, p = 0.048).  Scale = 
20µm.  
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Figure S4.  Beryllium delays ECM deposition and disrupts pattern formation in 
regenerating limb buds of the axolotl.  (A, C) Extracellular matrix is visible among the 
undifferentiated blastema cell populations of the control regenerates.  (E) Basal lamina 
can be seen beneath the epidermis, followed by signs of early limb patterning of the 
untreated palette.  (B, D, F) Very little ECM is visible in the mesenchyme of the blastema 
or palette of the treatment group.  (B) An edema is present in the sub-epidermal space of 
the treated early blastema (green arrow).  (F) Visible lack of discernable patterning or 
basal lamina in the treated equivalent of a palette.  (A-F) Treated blastemas have fewer 
cells present in the mesenchyme than their untreated counterparts.  This disparity 
disappears during the later stages of limb regeneration.  Scale = 100µm. 
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